Status:
COMPLETED
Effect of Cilostazol on Coronary Artery Stenosis and Plaque Characteristics in Patients With T2DM
Lead Sponsor:
Seoul National University Bundang Hospital
Conditions:
Coronary Artery Disease
Eligibility:
All Genders
30-80 years
Phase:
PHASE3
Brief Summary
This is a prospective interventional study to assess the effect of cilostazol compared with aspirin in Korean T2DM patients with atherosclerosis.
Detailed Description
Type 2 diabetes has been increased exponentially, arousing serious economic, social and health repercussions. Also, macrovascular complications of diabetes such as myocardial infarct or stroke have be...
Eligibility Criteria
Inclusion
- Type 2 diabetes with HbA1c ≥ 6.0% at screening visit
- Male or female between 30 and 80 years of age
- Coronary artery stenosis: 25-75% without no evidence of acute coronary syndrome
- No history of previous myocardial infarction
- Estimated GFR ≥ 60 ml/min/1.73m²
Exclusion
- SBP/DBP\> 160/110
- Congestive heart failure
- Allegy to radiocontrast dye
- Allegy to aspirin or cilostazol
- Acute bleeding
- History of ulcer bleeding
- GOT/GPT \> 100/100
- Other antiplatlet medication
Key Trial Info
Start Date :
February 1 2011
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
November 1 2016
Estimated Enrollment :
100 Patients enrolled
Trial Details
Trial ID
NCT02266030
Start Date
February 1 2011
End Date
November 1 2016
Last Update
October 9 2017
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Seoul National University Bundang Hospital
Seongnam, Bundang-gu, South Korea, 463-707